TP53:

Ayalew Tefferi1, Maymona Abdelmagid1, Giuseppe G Loscocco1,2

  • 1Division of Hematology, Mayo Clinic, Rochester, Minnesota, USA.

PubMed
概括

TP53突变 (TP53 MUT) 显著影响了骨髓增殖性瘤 (MPN) 的存活率. 在MPN爆发/加速阶段或MF-CP的多击TP53MUT表明预后不佳,而非多击TP53MUT可能不会影响MF-CP,PV或ET的短期生存.